count it a blessing that phase 3 was modified... http://www.fiercebiotech.com/biotech/merck-bristol-showdown-awaits-as-keytruda-lung-cancer-trial-stopped-strong-results waiting until year end to get results on a dead avenue would have been worthless and wasted time... the landscape has changed and how well does bavi help others is the question that is being asked... the playing field has been leveled as far as suitors go (if any)... merck is a potential player... assuming my intel has not changed...